FLUZONE, a new high strength influenza vaccine for over-65s, is expected to be added to the National Immunisation Program this year, with Australian Doctor reporting manufacturer Sanofi is ramping up production to ensure availability for the 2018 season.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Feb 18
